Impact Factor 5.810 | CiteScore 6.2
More on impact ›
Submit your manuscript
Scope
Pharmacoepidemiology is the study of the utilization and effects of medications in large human populations, bridging clinical pharmacology and epidemiology. We welcome all submissions that provide insight into pharmacoepidemiological or real-world evidence drug research.
Read More
Scope
Pharmacoepidemiology is the study of the utilization and effects of medications in large human populations, and it is a bridge science spanning both clinical pharmacology and epidemiology. It estimates the risks and benefits of medication use on various important physical and mental health outcomes.
Pharmacoepidemiology research is essential to identify rare but severe adverse outcomes once a drug is marketed; study risks and benefits in populations excluded from randomized clinical trials; and is increasingly being used for public health and clinical decisions.
The Pharmacoepidemiology section of Frontiers in Pharmacology publishes high-quality epidemiological, clinical, and translational original research across the fields of clinical pharmacology, epidemiology, and real-world evidence.
Areas covered by this section include, but are not limited to:
- Post-marketing observational studies on medications
- Post-marketing studies in populations routinely excluded from clinical trials such as children, pregnant women, and elderlies
- Observational studies on First Nations, racialized groups, and immigrant populations
- Real-world evidence using large population-based administrative or clinical databases
- Pharmacoepidemiologic real world evidence methodology
- Novel pharmacoepidemiologic methodology such as artificial intelligence and deep learning models
- Pharmacoeconomic studies
All studies must contribute insights into pharmacoepidemiological or real-world evidence drug research. Reports dealing with basic pharmacology, target identification, medicinal chemistry, biopharmacy or epidemiology unrelated to drugs do not fall within the scope of this section and might be submitted to other sections in Frontiers in Pharmacology or to other Frontiers journals.
Indexed in: Chemical Abstracts Service (CAS), CrossRef, DOAJ, Google Scholar, PubMed, PubMed Central (PMC), Scopus, Web of Science Science Citation Index Expanded (SCIE)
Pharmacoepidemiology welcomes submissions of the following article types: Brief Research Report, Clinical Trial, Correction, Data Report, Editorial, Erratum, General Commentary, Hypothesis and Theory, Methods, Mini Review, Opinion, Original Research, Perspective, Policy and Practice Reviews, Policy Brief, Protocols, Review, Study Protocol, Systematic Review and Technology and Code.
All manuscripts must be submitted directly to the section Pharmacoepidemiology, where they are peer-reviewed by the Associate and Review Editors of the specialty section.
Frontiers Editorial Office
Avenue du Tribunal Fédéral 34
CH – 1005 Lausanne
Switzerland
Tel +41 (0)21 510 17 00
Fax +41 (0)21 510 17 01
Frontiers Support
Tel +41 (0)21 510 17 10
Fax +41 (0)21 510 17 01
support@frontiersin.org
There are no results to display.
Click on any of the keywords to find further editors related to it.
- Article(s) found
- Latest
- Most viewed
This section has no articles.
There are no articles to display. Please try changing the filters.
- Research Topic(s) found
- Latest
- Most viewed
Contact Editorial Office
Avenue du Tribunal Fédéral 34
CH – 1005 Lausanne
Switzerland
Tel +41(0)21 510 17 40
Fax +41 (0)21 510 17 01
For all queries regarding manuscripts in Review and potential conflicts of interest, please contact pharmacology.editorial.office@frontiersin.org
For queries regarding Research Topics, Editorial Board applications, and journal development, please contact pharmacology@frontiersin.org
Tel +41(0)21 510 17 10
Fax +41 (0)21 510 17 01
For technical issues, please visit our Frontiers Help Center, or contact our IT HelpDesk team at support@frontiersin.org